Daniel Salvadori - Abbott Laboratories Ex Products
| ABL Stock | 112.04 1.16 1.05% |
Insider
Daniel Salvadori is Ex Products of Abbott Laboratories
| Age | 44 |
| Phone | 224 667 6100 |
| Web | https://www.abbott.com |
Abbott Laboratories Management Efficiency
The company has return on total asset (ROA) of 0.0738 % which means that it generated a profit of $0.0738 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1901 %, meaning that it generated $0.1901 on every $100 dollars invested by stockholders. Abbott Laboratories' management efficiency ratios could be used to measure how well Abbott Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 3 records | INSIDER Age | ||
| Aldis CFA | National Bank Holdings | 49 | |
| Charlie Koch | National Bank Holdings | N/A | |
| Angela Petrucci | National Bank Holdings | 46 | |
Management Performance
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0738 |
Abbott Laboratories Leadership Team
Elected by the shareholders, the Abbott Laboratories' board of directors comprises two types of representatives: Abbott Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Abbott. The board's role is to monitor Abbott Laboratories' management team and ensure that shareholders' interests are well served. Abbott Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Abbott Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Scott Leinenweber, Licensing Relations | ||
| Robert Ford, Pres Chairman | ||
| James Young, VP Officer | ||
| Elaine Leavenworth, VP Officer | ||
| Mary Moreland, Ex HR | ||
| Robert Funck, Exec CFO | ||
| Daniel Salvadori, Ex Products | ||
| Andrea Wainer, Ex Diagnostics | ||
| Hubert Allen, Gen VP | ||
| Melissa Brotz, VP Marketing |
Abbott Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Abbott Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0738 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 183.73 B | |||
| Shares Outstanding | 1.74 B | |||
| Shares Owned By Insiders | 0.70 % | |||
| Shares Owned By Institutions | 76.37 % | |||
| Price To Book | 5.28 X | |||
| Price To Sales | 4.09 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.